ArticleBiotech (Basel (Switzerland))2026

Engineering Viral Surface Antigens to Improve Display on Virus-like Particle (VLP) Vaccine Prototypes.

Mona Pißarreck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.